Digoxin
Mostrando 1-12 de 172 artigos, teses e dissertações.
-
1. Impact of chrysosplenetin, per se or in combination with artemisinin, on breast cancer resistance protein (Bcrp)/ABCG2 mRNA expression levels in mice small intestine
ABSTRACT Our previous work revealed that chrysosplenetin in combination with artemisinin inhibited in vivo P-glycoprotein (P-gp, one of classic multi-drug resistance proteins) mediated digoxin transportation activity by reversing the upregulated P-gp/Mdr1 mRNA expression levels by artemisinin. Therefore, chrysosplenetin might be a potential artemisinin-resis
Rev. bras. farmacogn.. Publicado em: 2017-12
-
2. Effects of warming yang and invigorating qi prescription on renin-angiotensin-aldosterone system in rats with heart failure after myocardial infarction
Abstract This study investigated the effects of warming yang and invigorating qi prescription on renin-angiotensin-aldosterone system (RAAS) in rats with heart failure after myocardial infarction. 126 rats were randomly divided into model group, sham operation, warming yang, invigorating qi, warming yang+invigorating qi, digoxin and captopril group for respe
Food Sci. Technol. Publicado em: 29/05/2017
-
3. Short-term follow-up of exercise training program and beta-blocker treatment on quality of life in dogs with naturally acquired chronic mitral valve disease
This study aimed to evaluate the effects of carvedilol treatment and a regimen of supervised aerobic exercise training on quality of life and other clinical, echocardiographic, and biochemical variables in a group of client-owned dogs with chronic mitral valve disease (CMVD). Ten healthy dogs (control) and 36 CMVD dogs were studied, with the latter group div
Braz J Med Biol Res. Publicado em: 04/08/2015
-
4. Study of digoxin use in a public health unit
A digoxina é usada para insuficiência cardíaca associada à disfunção sistólica e alta frequência ventricular. Possui janela terapêutica estreita, e a intoxicação pode ocorrer por interações medicamentosas ou comorbidades. O objetivo deste trabalho foi estudar o uso de digoxina em uma unidade pública de saúde, determinando o perfil de pacientes
An. Acad. Bras. Ciênc.. Publicado em: 15/05/2015
-
5. Uso de fármacos e consumo de nutrientes por idosos
Background : Physiological changes related to aging leads to nutritional deficiencies that may be aggravated by inadequate intake of nutrients in the diet and polypharmacy. Objectives : The paper 1 had the objective of analyzing the potential pharmacological interactions among drugs taken by elderly patients. The paper 2 aimed to determine the profile of nut
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 29/10/2012
-
6. Produção e caracterização da porção Fab do anticorpo anti-digoxina utilizando a tecnologia de phage display. / Production and characterization of the Fab portion of anti-digoxin antibody by phage display technology.
Digoxin is a pharmaceutical used in the control of cardiac dysfunction. Its therapeutic window is very narrow. To counteract the toxic effect, polyclonal anti-digoxin Fab fragments are commercially available. Our goal was to obtain variants of monoclonal anti-digoxin Fab fragments by phage display technology, which allows the generation of high affinity and
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 27/03/2012
-
7. Monitoração terapêutica das concentrações plásmaticas da digoxina em pacientes com insuficiência cardíaca / Therapeutical monitoring of digoxinemia in heart failure outpatients
Investigou-se o perfil clínico, laboratorial e as concentrações de digoxina plasmática em 15 pacientes com insuficiência cardíaca (IC) atendidos no Ambulatório de Insuficiência Cardíaca do HC-UFG. Objetivou-se estudar o perfil de concentrações plasmáticas de digoxina em pacientes com IC, utilizando dois métodos analíticos, e descrever a digoxin
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 27/10/2008
-
8. Therapeutical monitoring of digoxinemia in heart failure outpatients / Monitoração terapêutica das concentrações plásmaticas da digoxina em pacientes com insuficiência cardíaca
Investigou-se o perfil clínico, laboratorial e as concentrações de digoxina plasmática em 15 pacientes com insuficiência cardíaca (IC) atendidos no Ambulatório de Insuficiência Cardíaca do HC-UFG. Objetivou-se estudar o perfil de concentrações plasmáticas de digoxina em pacientes com IC, utilizando dois métodos analíticos, e descrever a digoxin
Publicado em: 2008
-
9. Determinantes prognósticos da cardiomiopatia chagásica na era atual do tratamento da insuficiência cardíaca crônica.
Conclusions: Lack of B-Blocking agent use, serum sodium levels <140mEq/L, left ventricular ejection fraction <0.32, digoxin treatment and New York Heart Association Class IV were powerful noninvasive independent predictors of all-cause mortality for patients with chronic heart failure secondary to Chagas cardiomyopathy in the current era of heart failure the
Publicado em: 2007
-
10. Mildly symptomatic chronic mitral regurgitation. Analysis of left ventricular systolic function and mitral regurgitant fraction under pharmacological influence: echocardiographic study
OBJECTIVE: To study echocardiographic parameters of left ventricular systolic function and valvar regurgitation under pharmacological influence in mildly symptomatic patients with chronic mitral regurgitation (MR). METHODS: We carried out a double-blind placebo controlled study in 12 patients with MR, mean aged 12.5 years old, who were randomized in 4 phases
Arquivos Brasileiros de Cardiologia. Publicado em: 2003-02
-
11. In vitro assay of biological and chemical toxins using antibodies against lethal toxin neutralizing factor
Lethal Toxin Neutralizing Factor (N-LTNF), MW 63.0 kDa, was isolated from opossum serum. After trypsin digestion, the active domain of N-LTNF was isolated and sequenced. The synthetic peptide consisting of ten amino acids was designated as LT-10. N-LTNF and LT-10 inhibited the lethality of animal, plant and bacteria toxins when tested on mice non-immunologic
Journal of Venomous Animals and Toxins. Publicado em: 2002
-
12. Erros de medicação em um hospital de referência de Minas Gerais, 2001
Aiming to evaluate the use of drugs and high-risk conditions predisposing to medication errors, there was a cross-sectional study in 4026 prescriptions containing potentially dangerous drugs (MPP) in a public hospital of reference of Minas Gerais, the period August-September 2001. The readability analysis showed that 19.4% of prescriptions were classified as
Publicado em: 2002